bioMérieux S.A. (EPA:BIM)
114.10
-0.10 (-0.09%)
Sep 24, 2025, 5:35 PM CET
bioMérieux Revenue
bioMérieux had revenue of 2.04B EUR in the half year ending June 30, 2025, with 15.46% growth. This brings the company's revenue in the last twelve months to 4.12B, up 8.28% year-over-year. In the year 2024, bioMérieux had annual revenue of 3.98B with 8.31% growth.
Revenue (ttm)
4.12B
Revenue Growth
+8.28%
P/S Ratio
3.27
Revenue / Employee
285.23K
Employees
14,754
Market Cap
13.47B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 3.98B | 305.20M | 8.31% |
Dec 31, 2023 | 3.67B | 85.60M | 2.39% |
Dec 31, 2022 | 3.59B | 212.90M | 6.31% |
Dec 31, 2021 | 3.38B | 258.00M | 8.27% |
Dec 31, 2020 | 3.12B | 443.40M | 16.58% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
EssilorLuxottica Société anonyme | 27.24B |
Sanofi | 45.74B |
Sartorius Stedim Biotech | 2.90B |
Eurofins Scientific SE | 7.14B |
Ipsen | 3.76B |
ABIVAX Société Anonyme | 6.02M |
Virbac | 1.43B |
emeis Société anonyme | 5.64B |
bioMérieux News
- 17 days ago - BioMérieux S.A. (BMXXY) Q2 2025 Earnings Call Transcript - Seeking Alpha
- 19 days ago - bioMérieux S.A. 2025 Q2 - Results - Earnings Call Presentation - Seeking Alpha
- 7 months ago - bioMérieux S.A. (BMXMF) Q4 2024 Earnings Call Transcript - Seeking Alpha
- 1 year ago - bioMérieux S.A. (BMXMF) Q2 2024 Earnings Call Transcript - Seeking Alpha
- 3 years ago - bioMérieux S.A. (BMXMF) CEO Alexandre Mérieux on Q4 2021 Results - Earnings Call Transcript - Seeking Alpha
- 4 years ago - bioMérieux S.A. (BMXMF) CEO Alexandre Mérieux on Q3 2021 Results - Earnings Call Transcript - Seeking Alpha
- 4 years ago - bioMérieux: Pioneering In Vitro Diagnostics - Seeking Alpha
- 4 years ago - bioMérieux S.A. (BMXMF) CEO Alexandre Mérieux on Q4 2020 Results - Earnings Call Transcript - Seeking Alpha